oxybutynin has been researched along with desogestrel in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mishell, DR; Roumen, FJ | 1 |
| Cannegieter, SC; Helmerhorst, FM; Lijfering, WM; Roach, RE; Rosendaal, FR; van Hylckama Vlieg, A | 1 |
| Bai, Y; Banga, AK; Kydonieus, A; Sachdeva, V | 1 |
| Cogque-Hernandez, G; Garcia-Latorre, EA; Hernandez-Giron, X; Hernandez-Juarez, J; Isordia-Salas, I; Julián-Nacer, R; Majluf-Cruz, A; Moran-Perez, JF; Moreno-Hernandez, M; Palafox-Gomez, R; Rodriguez-Escobedo, MA | 1 |
| Ackerman, KE; Baskaran, C; Bouxsein, ML; Campoverde Reyes, KJ; Eddy, KT; Klibanski, A; Lee, H; Misra, M; Singhal, V; Slattery, M; Toth, A | 1 |
| Gray, S | 1 |
2 review(s) available for oxybutynin and desogestrel
| Article | Year |
|---|---|
The contraceptive vaginal ring, NuvaRing(®), a decade after its introduction.
Topics: Administration, Intravaginal; Contraception Behavior; Contraceptive Agents; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Desogestrel; Dose-Response Relationship, Drug; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Patient Acceptance of Health Care; Transdermal Patch; Treatment Outcome | 2012 |
Choice of contraceptives.
Topics: Contraception; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Drug Implants; Female; Humans; Intrauterine Devices, Medicated; Patient Selection; Risk Factors; Sterilization, Reproductive; Transdermal Patch | 2015 |
1 trial(s) available for oxybutynin and desogestrel
| Article | Year |
|---|---|
Oestrogen replacement improves bone mineral density in oligo-amenorrhoeic athletes: a randomised clinical trial.
Topics: Absorptiometry, Photon; Administration, Oral; Adolescent; Adult; Amenorrhea; Athletes; Bone Density; Desogestrel; Estradiol; Estrogen Replacement Therapy; Ethinyl Estradiol; Female; Humans; Transdermal Patch; Young Adult | 2019 |
4 other study(ies) available for oxybutynin and desogestrel
| Article | Year |
|---|---|
The risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapy.
Topics: Administration, Cutaneous; Age Factors; Aged; Case-Control Studies; Contraceptives, Oral, Hormonal; Desogestrel; Estradiol; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Levonorgestrel; Logistic Models; Medroxyprogesterone Acetate; Middle Aged; Netherlands; Norethindrone; Norethindrone Acetate; Odds Ratio; Postmenopause; Progestins; Risk Assessment; Risk Factors; Sex Factors; Transdermal Patch; Venous Thrombosis | 2013 |
Formulation and optimization of desogestrel transdermal contraceptive patch using crystallization studies.
Topics: Adhesives; Animals; Contraceptives, Oral, Synthetic; Crystallization; Desogestrel; Excipients; Levonorgestrel; Male; Mineral Oil; Pyrrolidines; Rats; Rats, Hairless; Reproducibility of Results; Skin Absorption; Solubility; Transdermal Patch; Vinyl Compounds | 2013 |
Metabolic effects of the contraceptive skin patch and subdermal contraceptive implant in Mexican women: a prospective study.
Topics: Adiponectin; Adult; C-Peptide; C-Reactive Protein; Contraceptive Agents, Female; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Insulin; Insulin-Like Growth Factor I; Leptin; Lipid Metabolism; Liver Function Tests; Longitudinal Studies; Mexico; Norgestrel; Oximes; Thyroid Function Tests; Transdermal Patch; Weight Gain | 2014 |
Tales from the clinic.
Topics: Aged; Contraceptives, Oral, Hormonal; Contraindications, Drug; Desogestrel; Estradiol; Estrogens; Female; Humans; Progestins; Transdermal Patch; Venous Thromboembolism | 2019 |